KRW 25350.0
(1.2%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 14.19 KRW | -99.6% |
2022 | 3586.29 KRW | -65.38% |
2021 | 10.35 Thousand KRW | 7.2% |
2020 | 9662.23 KRW | 1783.18% |
2019 | 513.08 KRW | 164.12% |
2018 | 194.26 KRW | 217.63% |
2017 | 61.16 KRW | -55.19% |
2016 | 136.48 KRW | 3.43% |
2015 | 131.96 KRW | -27.49% |
2014 | 182.00 KRW | -6.67% |
2013 | 195.00 KRW | -16.31% |
2012 | 233.00 KRW | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -45.07 KRW | -135.58% |
2024 Q2 | 521.07 KRW | 1255.98% |
2023 Q2 | -53.89 KRW | -228.37% |
2023 Q1 | 41.98 KRW | -19.27% |
2023 FY | - KRW | -99.6% |
2023 Q4 | 126.69 KRW | 225.96% |
2023 Q3 | -100.58 KRW | -86.64% |
2022 Q3 | -217.37 KRW | -144.01% |
2022 Q2 | 493.86 KRW | -84.54% |
2022 Q4 | 52.00 KRW | 123.92% |
2022 Q1 | 3194.60 KRW | 0.65% |
2022 FY | - KRW | -65.38% |
2021 Q1 | 3166.89 KRW | -11.72% |
2021 Q3 | 1792.82 KRW | -19.43% |
2021 FY | - KRW | 7.2% |
2021 Q4 | 3174.09 KRW | 77.04% |
2021 Q2 | 2225.12 KRW | -29.74% |
2020 Q1 | 646.73 KRW | 496.23% |
2020 Q3 | 2914.76 KRW | 15.97% |
2020 Q4 | 3587.32 KRW | 23.07% |
2020 FY | - KRW | 1783.18% |
2020 Q2 | 2513.43 KRW | 288.64% |
2019 FY | - KRW | 164.12% |
2019 Q3 | 113.36 KRW | -42.07% |
2019 Q4 | 108.47 KRW | -4.31% |
2019 Q2 | 195.70 KRW | 104.81% |
2019 Q1 | 95.55 KRW | -11.96% |
2018 Q1 | 14.50 KRW | -49.23% |
2018 FY | - KRW | 217.63% |
2018 Q4 | 108.53 KRW | 135.68% |
2018 Q3 | 46.05 KRW | 82.16% |
2018 Q2 | 25.28 KRW | 74.34% |
2017 Q3 | 27.13 KRW | 39.13% |
2017 Q2 | 19.50 KRW | 542.18% |
2017 Q1 | -4.41 KRW | -105.34% |
2017 Q4 | 28.56 KRW | 5.27% |
2017 FY | - KRW | -55.19% |
2016 FY | - KRW | 3.43% |
2016 Q1 | 23.46 KRW | 1575.71% |
2016 Q2 | 38.59 KRW | 64.49% |
2016 Q3 | -10.00 KRW | -125.91% |
2016 Q4 | 82.64 KRW | 926.4% |
2015 Q2 | 39.49 KRW | 17.78% |
2015 Q1 | 33.53 KRW | -32.97% |
2015 Q4 | 1.40 KRW | -97.59% |
2015 FY | - KRW | -27.49% |
2015 Q3 | 58.00 KRW | 46.87% |
2014 Q1 | 72.45 KRW | 161.08% |
2014 FY | - KRW | -6.67% |
2014 Q4 | 50.02 KRW | 3.13% |
2014 Q3 | 48.50 KRW | 84.48% |
2014 Q2 | 26.29 KRW | -63.71% |
2013 Q4 | 27.75 KRW | -45.23% |
2013 Q2 | 63.67 KRW | 19.46% |
2013 FY | - KRW | -16.31% |
2013 Q3 | 50.67 KRW | -20.42% |
2013 Q1 | 53.30 KRW | -76.36% |
2012 Q4 | 225.49 KRW | 555.49% |
2012 Q3 | 34.40 KRW | 0.0% |
2012 FY | - KRW | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 9148.00 KRW | 99.845% |
InBody Co.,Ltd | 2819.01 KRW | 99.497% |
Curexo Inc. | -120.00 KRW | 111.825% |
i-SENS, Inc. | 134.89 KRW | 89.48% |
Ray Co., Ltd. | -140.25 KRW | 110.118% |
Gencurix Inc. | -1629.25 KRW | 100.871% |
Sugentech Inc. | -1090.00 KRW | 101.302% |
L&C Bio Co., Ltd | 2096.33 KRW | 99.323% |